These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32783380)

  • 1. Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand.
    Aikphaibul P; Theerawit T; Sophonphan J; Wacharachaisurapol N; Jitrungruengnij N; Puthanakit T
    Influenza Other Respir Viruses; 2021 Jan; 15(1):64-71. PubMed ID: 32783380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes.
    Cai W; Buda S; Schuler E; Hirve S; Zhang W; Haas W
    Influenza Other Respir Viruses; 2020 Nov; 14(6):658-670. PubMed ID: 32064773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
    Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
    Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, clinical features, and resource utilization associated with respiratory syncytial virus in the community and hospital.
    Smithgall M; Maykowski P; Zachariah P; Oberhardt M; Vargas CY; Reed C; LaRussa P; Saiman L; Stockwell MS
    Influenza Other Respir Viruses; 2020 May; 14(3):247-256. PubMed ID: 32077641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines.
    Ueno F; Tamaki R; Saito M; Okamoto M; Saito-Obata M; Kamigaki T; Suzuki A; Segubre-Mercado E; Aloyon HD; Tallo V; Lupisan SP; Oshitani H;
    Influenza Other Respir Viruses; 2019 Jul; 13(4):339-353. PubMed ID: 30891896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and epidemiological impact of respiratory syncytial virus and identification of risk factors for severe disease in children hospitalized due to acute respiratory tract infection.
    Ferolla FM; Soffe J; Mistchenko A; Contrini MM; López EL
    Arch Argent Pediatr; 2019 Aug; 117(4):216-223. PubMed ID: 31339263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.
    Moe N; Krokstad S; Stenseng IH; Christensen A; Skanke LH; Risnes KR; Nordbø SA; Døllner H
    PLoS One; 2017; 12(1):e0170200. PubMed ID: 28095451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RSV frequency in children below 2 years hospitalized for lower respiratory tract infections.
    Hacımustafaoğlu M; Celebi S; Bozdemir SE; Ozgür T; Ozcan I; Güray A; Cakır D
    Turk J Pediatr; 2013; 55(2):130-9. PubMed ID: 24192672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus infection in children with severe motor and intellectual disabilities.
    Onoyama S; Hoshina T; Honjo S; Ihara K; Hara T
    Eur J Clin Microbiol Infect Dis; 2013 Oct; 32(10):1353-7. PubMed ID: 23681154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI).
    Straňák Z; Saliba E; Kosma P; Posfay-Barbe K; Yunis K; Farstad T; Unnebrink K; van Wyk J; Wegzyn C; Notario G; Kalus S; Campbell FJ
    PLoS One; 2016; 11(6):e0157446. PubMed ID: 27310438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric intensive care unit admission due to respiratory syncytial virus: Retrospective multicenter study.
    Kang JM; Lee J; Kim YK; Cho HK; Park SE; Kim KH; Kim MJ; Kim S; Kim YJ
    Pediatr Int; 2019 Jul; 61(7):688-696. PubMed ID: 31107995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Respiratory Syncytial Virus-related Hospitalizations and the Influence of Viral Coinfections in Southern Austria in a 7-year Period.
    Resch B; Puchas C; Resch E; Urlesberger B
    Pediatr Infect Dis J; 2020 Jan; 39(1):12-16. PubMed ID: 31651808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Manifestations and Outcomes of Respiratory Syncytial Virus Infection in Children Less Than Two Years in Colombia.
    Buendía JA; Polack FP; Patiño DG
    Indian Pediatr; 2021 Nov; 58(11):1091-1092. PubMed ID: 32893827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study.
    Zachariah P; Ruttenber M; Simões EA
    J Pediatr; 2012 May; 160(5):827-31.e1. PubMed ID: 22177993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus (RSV) infection in children with medical complexity.
    Lim A; Butt ML; Dix J; Elliott L; Paes B
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):171-176. PubMed ID: 30374685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characterisation and phylogeny of respiratory syncytial virus infection in hospitalised children at Red Cross War Memorial Children's Hospital, Cape Town.
    Oladokun R; Muloiwa R; Hsiao NY; Valley-Omar Z; Nuttall J; Eley B
    BMC Infect Dis; 2016 May; 16():236. PubMed ID: 27246848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008-2011.
    Naorat S; Chittaganpitch M; Thamthitiwat S; Henchaichon S; Sawatwong P; Srisaengchai P; Lu Y; Chuananon S; Amornintapichet T; Chantra S; Erdman DD; Maloney SA; Akarasewi P; Baggett HC
    J Infect Dis; 2013 Dec; 208 Suppl 3():S238-45. PubMed ID: 24265483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Respiratory Syncytial Virus Infection in Hospitalized Children.
    González-Ortiz AM; Bernal-Silva S; Comas-García A; Vega-Morúa M; Garrocho-Rangel ME; Noyola DE
    Arch Med Res; 2019 Aug; 50(6):377-383. PubMed ID: 31678896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study.
    Papenburg J; Defoy I; Massé E; Caouette G; Lebel MH
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):237-244. PubMed ID: 32530035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
    Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D
    Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.